Platinum Analytics Cayman Limited Class A Ordinary Shares (PLTS)vsZepp Health Corp (ZEPP)
PLTS
Platinum Analytics Cayman Limited Class A Ordinary Shares
$17.50
0.00%
TECHNOLOGY · Cap: $316.03M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 15355% more annual revenue ($258.90M vs $1.68M). ZEPP leads profitability with a -15.5% profit margin vs -120.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
PLTS
Avoid12
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for PLTS.
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Trading at 58.3x book value
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : PLTS
PLTS has a balanced fundamental profile.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : PLTS
The primary concerns for PLTS are EPS Growth, Market Cap, P/E Ratio. A P/E of 1750.0x leaves little room for execution misses.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
PLTS profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 12/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Platinum Analytics Cayman Limited Class A Ordinary Shares
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Platinum Analytics Cayman Limited (Ticker: PLTS) is a leading provider of advanced analytical solutions, empowering institutional investors to enhance their investment decision-making processes. Leveraging cutting-edge technology and comprehensive data analytics, the company delivers critical market intelligence that supports strategic investment initiatives. With a dedication to innovation and forging strategic partnerships, Platinum Analytics is well-equipped to meet the increasing demand for precision in financial analysis, reinforcing its status as a significant player in the evolving fintech landscape.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?